Influence of Menstrual Cycle Phase on Adaptations to Sprint Interval Training

NCT ID: NCT06744517

Last Updated: 2025-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-01

Study Completion Date

2025-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sprint interval training improves endurance performance and induces metabolic adaptations in muscle. Most research demonstrating these responses has been conducted in males, with limited studies evaluating changes to endurance performance and skeletal muscle oxidative capacity in females. Moreover, it is currently unknown if training in specific phases of the menstrual cycle influences adaptations to training. Thus, the purpose of the present study is to compare adaptations to 2 weeks of sprint interval training performed in the follicular vs. luteal phase of the menstrual cycle in healthy, eumenorrheic women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary purpose of the present study is to determine if menstrual cycle phase influences adaptations to 2 weeks of sprint interval training. Participants will be randomized to perform 6 sessions of sprint interval training over 2 weeks in either the Follicular Phase or Luteal Phase of their individual menstrual cycle. Blood and urine sampling will be used to confirm menstrual cycle phases. Training will involve 4-6 x 30-second Wingate sprints with 4 minutes of rest in between (\~14-28 min per session). Before and after the training intervention, investigators will measure participant's aerobic and anaerobic performance, cardiorespiratory fitness and skeletal muscle outcomes. Performance and fitness measures are performed on on a stationary bike, and muscle outcomes are measured by taking a small amount of muscle from the vastus lateralis (thigh) muscle.

This study will advance knowledge on how the menstrual cycle influences adaptations to training in females

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Follicular Phase Training

Exercise training in the follicular phase (\~days 1-14) of the participant's menstrual cycle

Group Type ACTIVE_COMPARATOR

Sprint Interval Training

Intervention Type OTHER

6 sessions of sprint interval training over 2 weeks. Each session involves 4-6 x 30 second Wingate sprints with 4 minutes of recovery in between on a stationary bike

Luteal Phase Training

Exercise training in the luteal phase (\~days 15-28) of the participant's menstrual cycle

Group Type EXPERIMENTAL

Sprint Interval Training

Intervention Type OTHER

6 sessions of sprint interval training over 2 weeks. Each session involves 4-6 x 30 second Wingate sprints with 4 minutes of recovery in between on a stationary bike

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sprint Interval Training

6 sessions of sprint interval training over 2 weeks. Each session involves 4-6 x 30 second Wingate sprints with 4 minutes of recovery in between on a stationary bike

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participating in 150 min of moderate-vigorous physical activity/week
* VO2peak of 'good' or above based on American College of Sport Medicine (ACSM) normative values(greater than 35.0ml/kg/min)
* Body mass index (BMI) between 18-27 kg/m2
* Performing 2-4 structured exercise sessions/week.
* Weight stable (within ± 2kg for at least 6 months)
* Non-smoker
* Menstrual cycle length of 27-35 days
* Minimal menstrual cycle length variability (less than 3 days)
* Ovulating monthly evidenced by a positive urinary luteinizing hormone surge
* Blood progesterone concentration greater than 16 nmol/L.

Exclusion Criteria

* Hormonal contraceptive use within the last 3 months
* Polycystic ovarian syndrome (PCOS) or endometriosis
* Failure to meet MC verification criteria.
* Diagnosed with cardiovascular or metabolic disease, hyper- or hypogonadism, and/or PCOS
* The use of medication for managing blood glucose or lipid metabolism
* Current use of oral contraceptives or use within the last 3 months
* Irregular menstrual cycles (\<27 days or \>35 days)
* Pregnant or post-partum in the last 12 months, lactating or breast feeding within 3 months of the start of study, or menopausal
* Recreational smoking tobacco
* Inability to perform the study exercise protocols or follow the pre-trial dietary or physical activity controls
* Taking medications affecting substrate metabolism (corticosteroids or nSAIDs)
* Actively engaging in a low-carbohydrate diet (e.g., ketogenic, Atkins)
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jenna Gillen

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Goldring Centre for High Performance Sport

Toronto, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jenna Gillen Assistant Professor, PhD

Role: CONTACT

4169783244

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jenna Gillen

Role: primary

4169783244

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSREB50581

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Resisted Training in Runners
NCT06729138 RECRUITING NA